The Only Product to Offer a Patient-Friendly, Portable, and Objective Measurement of Gas Exchange

MediPines Gas Exchange Monitor

Rapid detection and assessment of respiratory gas exchange efficiency. Impaired gas exchange may be caused by:
  • COPD
  • Pulmonary fibrosis
  • Pulmonary embolism
  • Pulmonary edema
  • Pneumonia
  • Hypoventilation, etc.

AGM100® Parameters

Comprehensive Assessments:
  • Oxygen deficit (PAO2-gPaO2TM)
  • Respiratory Quotient (RQ)
  • Oxygen Saturation(SpO2)
  • Arterial O2 (gPaO2TM)
  • Alveolar O2 (PAO2)
  • End Tidal CO2 (PETCO2)
  • Pulse Rate (PR)
  • Respiratory Rate (RR)
  • A range of respiratory gas indices

MediPines Gas Exchange Monitor (AGM100®)

To schedule a meeting tailored to your clinical situation and needs, and to learn more about how the AGM100® can benefit your practice, click below.
So, what makes the MediPines Gas Exchange Monitor interesting?
Simply put, it’s new. The Gas Exchange Monitor is the first medical device to integrate a “comprehensive set” of respiratory parameters and indicators drawn from a patient’s breath in a noninvasive test. What’s key is the word “noninvasive.”

MedTech Boston

MediPines Corporation is a pioneering medical device company, established to advance respiratory medicine. The company is based in Orange County, California and is focused on innovative devices for respiratory diagnostics and management by partnering with world-class medical institutions, focusing on patient outcomes, and achieving meaningful long-term results.

Our mission is to improve patient outcomes by empowering clinicians with non-invasive, practical devices for the most significant respiratory challenges they face.

The MediPines Gas Exchange Monitor (AGM100®) is built on patented technologies and manufactured in the USA.